Uterine leiomyosarcoma is a rare and aggressive cancer that occurs in the uterus. Individuals usually require a hysterectomy. Treatments can also include chemotherapy or radiotherapy. Leiomyosarcoma ...
For patients with metastatic or surgically unresectable leiomyosarcoma, combination therapy with doxorubicin and trabectedin is associated with improved overall and progression-free survival compared ...
Uterine leiomyosarcoma is a rare form of cancer. The earlier uterine leiomyosarcoma is diagnosed, the better the outlook. Uterine leiomyosarcoma accounts for 2–5% of all uterine cancers. It starts in ...
Editor's Note: Uterine leiomyosarcomas are aggressive, heterogeneous cancers associated with high rates of progression and recurrence—and poor outcome. Uterine sarcomas as a group are uncommon cancers ...
A phase Ib/II study of the combination of lenvatinib (L) and eribulin (E) in advanced liposarcoma (LPS) and leiomyosarcoma (LMS) (LEADER): Efficacy updates. Neoadjuvant chemotherapy in high-risk soft ...
Soft Tissue and Uterine Leiomyosarcoma The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held ...
An oral combination treatment may prevent the progression of advanced leiomyosarcoma, one of the most common subtypes of soft tissue sarcoma, according to a recent study published in The Lancet ...
Inflammatory leiomyosarcoma, first described by Merchant et al., 1 is a spindle cell tumor of the deep soft tissues that shares morphological features with conventional leiomyosarcoma but that also ...
Leiomyosarcoma (LMS) is a type of soft tissue sarcoma — and a very rare type of cancer. Doctors often find LMS cancer in the uterus. But it can occur in any of your body’s smooth muscles. This cancer ...
Clinical Trials for Leiomyosarcoma New clinical trials come up depending on what cancer researchers are working on. Some of the current ones for leiomyosarcoma are for a type of treatment called ...
“Laryngeal leiomyosarcoma (LLMS) is an exceptionally rare malignant tumor, accounting for less than 1 % of all laryngeal cancers, which are predominantly epithelial in origin.” The study was led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results